Edgestream Partners, L.P. Edwards Lifesciences Corp Transaction History

Edgestream Partners, L.P.

$2.05 Billion
Q2 2024

A detailed history of Edgestream Partners, L.P. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Edgestream Partners, L.P. holds 4,742 shares of EW stock, worth $310,506. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,742

Holding current value

$310,506

% of portfolio

0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$84.3 - $94.31 $399,750 - $447,218	4,742 New	4,742 $438,000
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $788,641 - $897,496	-10,620 Reduced 46.63%	12,153 $1.01 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $7.93 Million - $10.2 Million	-116,129 Reduced 83.6%	22,773 $1.7 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $8.03 Million - $10.5 Million	97,538 Added 235.8%	138,902 $11.5 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $1.59 Million - $2.36 Million	18,379 Added 79.96%	41,364 $3.93 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $2.34 Million - $2.95 Million	22,985 New	22,985 $2.71 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $3.82 Million - $4.56 Million	-37,127 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$83.84 - $104.76 $2.01 Million - $2.51 Million	23,979 Added 182.38%	37,127 $3.85 Million
Q1 2021 May 06, 2021	BUY	$78.68 - $90.67 $309,999 - $357,239	3,940 Added 42.79%	13,148 $1.1 Million
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $183,598 - $233,640	-2,561 Reduced 21.76%	9,208 $840,000
Q3 2020 Nov 10, 2020	SELL	$67.19 - $87.44 $14.5 Million - $18.9 Million	-216,075 Reduced 94.83%	11,769 $939,000
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $10.5 Million - $14 Million	182,557 Added 403.11%	227,844 $15.7 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $84,118 - $130,005	1,605 Added 3.67%	45,287 $8.54 Million
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $94,285 - $107,948	-1,315 Reduced 2.92%	43,682 $10.2 Million
Q3 2019 Nov 08, 2019	BUY	$61.55 - $75.43 $1.34 Million - $1.65 Million	21,835 Added 94.27%	44,997 $9.9 Million
Q2 2019 Aug 08, 2019	BUY	$55.74 - $64.41 $607,566 - $702,069	10,900 Added 88.89%	23,162 $4.28 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $587,227 - $785,381	12,262 New	12,262 $2.35 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $997,907 - $1.22 Million	-21,502 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$45.7 - $58.03 $773,426 - $982,099	-16,924 Reduced 44.04%	21,502 $3.74 Million
Q2 2018 Aug 09, 2018	SELL	$42.45 - $51.3 $35,997 - $43,502	-848 Reduced 2.16%	38,426 $5.59 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $1.46 Million - $1.86 Million	39,274 New	39,274 $5.48 Million
Q4 2017 Feb 09, 2018	SELL	$33.79 - $39.39 $102,316 - $119,272	-3,028 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$36.29 - $38.83 $109,886 - $117,577	3,028	3,028 $331,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Account

Edgestream Partners, L.P. Edwards Lifesciences Corp Transaction History